2023 NICE 技术鉴定指导意见：Axicabtagene ciloleucel 治疗弥漫性大 B 细胞淋巴瘤和原发性纵隔大 B 细胞淋巴瘤 2 次或以上全身治疗后[TA872].pdfVIP

Axicabtagenecilleucelfor

treatingdiffuselargeB-cell

lymphomaandprimary

mediastinallargeB-cell

lymphomaafter2ormore

systemictherapies

Technologyappraisalguidance

Published:28February2023

.uk/guidance/ta872

©NICE2023.Allrightsreserved.SubjecttoNoticeofrights(.uk/terms-and-

conditions#notice-of-rights).

AxicabtageneciloleucelfortreatingdiffuselargeB-celllymphomaandprimarymediastinal

largeB-celllymphomaafter2ormoresystemictherapies(TA872)

Yourresponsibility

Therecommendationsinthisguidancerep